Stocks · Health care · Pharmaceutical Preparations

TEVA PHARMACEUTICAL INDUSTRIES LTD

TEVA Clue Score52
Israel Fiscal year ends December CIK 0000818686
41.10
+4.71%
Close, 9 Oct 2026 · USD

Price, with every insider trade on it

Closing prices, 12 months · point at a dot for who traded, or at the line for the close
41.10 on 9 Oct 2026
41 30 19 Oct 2025 Apr 2026 Oct 2026 13 Oct 2025 $20.02 14 Oct 2025 $20.11 15 Oct 2025 $19.78 16 Oct 2025 $19.63 17 Oct 2025 $19.31 20 Oct 2025 $19.42 21 Oct 2025 $18.99 22 Oct 2025 $18.97 23 Oct 2025 $19.02 24 Oct 2025 $18.95 27 Oct 2025 $19.61 28 Oct 2025 $19.78 29 Oct 2025 $20.23 30 Oct 2025 $20.03 31 Oct 2025 $20.48 3 Nov 2025 $20.52 4 Nov 2025 $20.46 5 Nov 2025 $24.60 6 Nov 2025 $24.46 7 Nov 2025 $23.97 10 Nov 2025 $24.26 11 Nov 2025 $25.13 12 Nov 2025 $25.83 13 Nov 2025 $25.54 14 Nov 2025 $25.41 17 Nov 2025 $24.59 18 Nov 2025 $24.84 19 Nov 2025 $24.44 20 Nov 2025 $24.28 21 Nov 2025 $24.21 24 Nov 2025 $24.77 25 Nov 2025 $24.99 26 Nov 2025 $26.32 28 Nov 2025 $26.89 1 Dec 2025 $26.72 2 Dec 2025 $26.88 3 Dec 2025 $27.83 4 Dec 2025 $28.41 5 Dec 2025 $28.46 8 Dec 2025 $28.33 9 Dec 2025 $28.56 10 Dec 2025 $29.80 11 Dec 2025 $30.18 12 Dec 2025 $29.79 15 Dec 2025 $30.13 16 Dec 2025 $30.10 17 Dec 2025 $30.06 18 Dec 2025 $30.32 19 Dec 2025 $30.35 22 Dec 2025 $31.21 23 Dec 2025 $31.54 24 Dec 2025 $31.74 26 Dec 2025 $31.89 29 Dec 2025 $31.56 30 Dec 2025 $31.34 31 Dec 2025 $31.21 2 Jan 2026 $30.95 5 Jan 2026 $31.00 6 Jan 2026 $32.11 7 Jan 2026 $32.40 8 Jan 2026 $32.51 9 Jan 2026 $32.01 12 Jan 2026 $32.79 13 Jan 2026 $32.47 14 Jan 2026 $32.64 15 Jan 2026 $32.35 16 Jan 2026 $31.76 20 Jan 2026 $31.36 21 Jan 2026 $31.41 22 Jan 2026 $31.66 23 Jan 2026 $31.81 26 Jan 2026 $32.14 27 Jan 2026 $32.53 28 Jan 2026 $33.21 29 Jan 2026 $33.07 30 Jan 2026 $34.08 2 Feb 2026 $35.52 3 Feb 2026 $36.25 4 Feb 2026 $34.96 5 Feb 2026 $34.80 6 Feb 2026 $34.69 9 Feb 2026 $34.47 10 Feb 2026 $34.37 11 Feb 2026 $34.31 12 Feb 2026 $33.92 13 Feb 2026 $33.98 17 Feb 2026 $34.41 18 Feb 2026 $34.11 19 Feb 2026 $34.33 20 Feb 2026 $34.22 23 Feb 2026 $33.91 24 Feb 2026 $33.92 25 Feb 2026 $33.62 26 Feb 2026 $33.77 27 Feb 2026 $33.86 2 Mar 2026 $33.77 3 Mar 2026 $32.28 4 Mar 2026 $32.91 5 Mar 2026 $31.75 6 Mar 2026 $31.05 9 Mar 2026 $31.50 10 Mar 2026 $31.52 11 Mar 2026 $30.47 12 Mar 2026 $29.30 13 Mar 2026 $28.57 16 Mar 2026 $29.46 17 Mar 2026 $30.09 18 Mar 2026 $29.61 19 Mar 2026 $29.44 20 Mar 2026 $28.73 23 Mar 2026 $28.77 24 Mar 2026 $29.14 25 Mar 2026 $29.46 26 Mar 2026 $29.78 27 Mar 2026 $28.74 30 Mar 2026 $28.35 31 Mar 2026 $30.12 1 Apr 2026 $30.25 2 Apr 2026 $30.08 6 Apr 2026 $29.82 7 Apr 2026 $29.33 8 Apr 2026 $30.52 9 Apr 2026 $30.96 10 Apr 2026 $30.82 13 Apr 2026 $31.15 14 Apr 2026 $31.77 15 Apr 2026 $31.61 16 Apr 2026 $31.26 17 Apr 2026 $32.40 20 Apr 2026 $32.02 21 Apr 2026 $31.29 22 Apr 2026 $31.22 23 Apr 2026 $31.21 24 Apr 2026 $30.64 27 Apr 2026 $31.26 28 Apr 2026 $31.62 29 Apr 2026 $35.38 30 Apr 2026 $35.07 1 May 2026 $34.95 4 May 2026 $35.35 5 May 2026 $35.86 6 May 2026 $36.34 7 May 2026 $36.01 8 May 2026 $35.73 11 May 2026 $35.84 12 May 2026 $35.81 13 May 2026 $36.25 14 May 2026 $35.31 15 May 2026 $34.29 18 May 2026 $34.03 19 May 2026 $34.07 20 May 2026 $34.32 21 May 2026 $34.16 22 May 2026 $34.07 26 May 2026 $34.61 27 May 2026 $34.56 28 May 2026 $34.52 29 May 2026 $35.32 1 Jun 2026 $34.64 2 Jun 2026 $33.08 3 Jun 2026 $32.83 4 Jun 2026 $34.43 5 Jun 2026 $34.19 8 Jun 2026 $33.26 9 Jun 2026 $34.45 10 Jun 2026 $33.58 11 Jun 2026 $34.56 12 Jun 2026 $34.63 15 Jun 2026 $33.69 16 Jun 2026 $32.91 17 Jun 2026 $32.56 18 Jun 2026 $31.48 22 Jun 2026 $32.20 23 Jun 2026 $33.21 24 Jun 2026 $34.22 25 Jun 2026 $33.62 26 Jun 2026 $33.21 29 Jun 2026 $33.31 30 Jun 2026 $33.88 1 Jul 2026 $33.44 2 Jul 2026 $34.64 6 Jul 2026 $35.29 7 Jul 2026 $34.65 8 Jul 2026 $33.24 9 Jul 2026 $33.10 10 Jul 2026 $32.95 13 Jul 2026 $32.18 14 Jul 2026 $31.82 15 Jul 2026 $31.56 16 Jul 2026 $32.22 17 Jul 2026 $32.03 20 Jul 2026 $31.00 21 Jul 2026 $31.35 22 Jul 2026 $30.15 23 Jul 2026 $31.18 24 Jul 2026 $30.81 27 Jul 2026 $31.08 28 Jul 2026 $31.67 29 Jul 2026 $34.71 30 Jul 2026 $35.41 31 Jul 2026 $35.01 3 Aug 2026 $34.46 4 Aug 2026 $34.43 5 Aug 2026 $34.72 6 Aug 2026 $34.81 7 Aug 2026 $35.36 10 Aug 2026 $36.14 11 Aug 2026 $36.48 12 Aug 2026 $36.74 13 Aug 2026 $36.52 14 Aug 2026 $36.77 17 Aug 2026 $36.46 18 Aug 2026 $36.58 19 Aug 2026 $37.47 20 Aug 2026 $36.81 21 Aug 2026 $37.34 24 Aug 2026 $36.93 25 Aug 2026 $38.10 26 Aug 2026 $37.92 27 Aug 2026 $37.62 28 Aug 2026 $36.44 31 Aug 2026 $36.05 1 Sep 2026 $36.19 2 Sep 2026 $37.49 3 Sep 2026 $36.62 4 Sep 2026 $36.36 8 Sep 2026 $36.76 9 Sep 2026 $36.85 10 Sep 2026 $36.35 11 Sep 2026 $37.09 14 Sep 2026 $38.72 15 Sep 2026 $39.25 16 Sep 2026 $38.53 17 Sep 2026 $39.19 18 Sep 2026 $38.98 21 Sep 2026 $40.06 22 Sep 2026 $39.52 23 Sep 2026 $39.01 24 Sep 2026 $40.22 25 Sep 2026 $39.19 28 Sep 2026 $38.88 29 Sep 2026 $39.81 30 Sep 2026 $39.60 1 Oct 2026 $39.31 2 Oct 2026 $39.53 5 Oct 2026 $39.66 6 Oct 2026 $39.13 7 Oct 2026 $39.18 8 Oct 2026 $39.25 9 Oct 2026 $41.10 Weiss Amir Chief Accounting Officer Sold at will $300.56K 6 Nov 2025 · at $24.44 · 40.7% of stake MIGNONE ROBERTO Director Sold at will $4.82M 6 Nov 2025 · at $24.11 · 28.8% of stake Fox Christine EVP, Head of U.S. Commercial Sold at will $753.32K 14 Nov 2025 · at $25.11 · 51.4% of stake Fox Christine EVP, Head of U.S. Commercial Sold on a plan $699.52K 20 Nov 2025 · at $24.78 · 30.7% of stake MIGNONE ROBERTO Director Sold at will $1.30M 26 Nov 2025 · at $26.03 · 10.1% of stake Daniell Richard Exec. VP, European Commercial Sold at will $3.31M 9 Dec 2025 · at $28.68 · 70.5% of stake Sabag Mark See "Remarks" Sold at will $6.23M 9 Dec 2025 · at $28.73 · 80.4% of stake Weiss Amir Chief Accounting Officer Sold at will $371.50K 16 Dec 2025 · at $30.20 · 68.5% of stake MIGNONE ROBERTO Director Sold at will $2.34M 16 Dec 2025 · at $30.24 · 17.4% of stake Francis Richard D President and CEO Sold on a plan $15.32M 15 Feb 2026 · at $34.22 · 62.2% of stake Kalif Eliyahu Sharon EVP, Chief Financial Officer Sold on a plan $11.63M 26 Feb 2026 · at $33.64 · 85.7% of stake Savage Brian Interim Chief Legal Officer Sold at will $41.23K 3 Mar 2026 · at $32.36 · 30.3% of stake Hughes Eric A See "Remarks" Sold on a plan $2.61M 3 Mar 2026 · at $32.36 · 86.3% of stake Daniell Richard EVP, Europe Commercial Sold on a plan $4.17M 3 Mar 2026 · at $32.36 · 72.7% of stake Francis Richard D President and CEO Sold on a plan $14.33M 3 Mar 2026 · at $32.36 · 40.8% of stake Savage Brian Interim Chief Legal Officer Sold at will $86.84K 4 Mar 2026 · at $32.46 · 30.2% of stake Fox Christine EVP, U.S. Commercial Sold on a plan $295.36K 4 Mar 2026 · at $32.46 · 10.8% of stake Hughes Eric A See "Remarks" Sold on a plan $366.10K 4 Mar 2026 · at $32.46 · 10.4% of stake Francis Richard D President and CEO Sold on a plan $759.44K 4 Mar 2026 · at $32.46 · 2.0% of stake Daniell Richard EVP, Europe Commercial Sold on a plan $2.98M 4 Mar 2026 · at $32.66 · 51.6% of stake Savage Brian Interim Chief Legal Officer Sold at will $35.69K 5 Mar 2026 · at $31.67 · 9.4% of stake Fox Christine EVP, U.S. Commercial Sold on a plan $250.94K 5 Mar 2026 · at $31.67 · 8.5% of stake Hughes Eric A See "Remarks" Sold on a plan $301.89K 5 Mar 2026 · at $31.67 · 8.1% of stake Jover Placid See "Remarks" Sold on a plan $448.11K 5 Mar 2026 · at $31.67 · 67.6% of stake Shields Matthew EVP, Global Operations Sold on a plan $547.70K 5 Mar 2026 · at $31.67 · 63.4% of stake Daniell Richard EVP, Europe Commercial Sold on a plan $547.70K 5 Mar 2026 · at $31.67 · 16.8% of stake Francis Richard D President and CEO Sold on a plan $634.16K 5 Mar 2026 · at $31.67 · 1.7% of stake Sabag Mark See "Remarks" Sold at will $1.87M 17 Mar 2026 · at $30.14 · 21.6% of stake Fox Christine EVP, U.S. Commercial Sold at will $750.62K 30 Apr 2026 · at $35.31 · 25.0% of stake Sabag Mark See "Remarks" Sold at will $5.05M 1 May 2026 · at $34.99 · 64.1% of stake Daniell Richard EVP, Europe Commercial Sold at will $1.06M 5 May 2026 · at $35.40 · 35.0% of stake Weiss Amir Chief Accounting Officer Sold at will $384.44K 6 May 2026 · at $36.00 · 34.8% of stake Lippman Evan EVP, Business Development Sold on a plan $1.48M 14 May 2026 · at $35.58 · 87.2% of stake Kalif Eliyahu Sharon EVP, Chief Financial Officer Sold on a plan $5.46M 14 May 2026 · at $35.61 · 47.1% of stake Shields Matthew EVP, Global Operations Sold on a plan $532.33K 3 Jun 2026 · at $32.87 · 61.9% of stake Francis Richard D President and CEO Sold on a plan $211.36K 5 Jun 2026 · at $34.35 · 0.5% of stake Kalif Eliyahu Sharon EVP, Chief Financial Officer Sold on a plan $3.63M 11 Jun 2026 · at $34.10 · 61.9% of stake Shields Matthew EVP, Global Operations Sold at will $321.55K 18 Jun 2026 · at $32.19 · 100% of stake Jover Placid See "Remarks" Sold on a plan $447.35K 3 Aug 2026 · at $34.88 · 65.4% of stake Hughes Eric A See "Remarks" Sold on a plan $892.05K 3 Aug 2026 · at $34.88 · 15.9% of stake Zaks Tal Zvi Director Sold at will $592.71 5 Aug 2026 · at $34.87 · 0.0% of stake Lippman Evan EVP, Business Development Sold on a plan $680.29K 17 Aug 2026 · at $36.57 · 42.1% of stake Satchi-Fainaro Ronit Director Sold at will $15.46K 21 Aug 2026 · at $37.25 · 0.4% of stake Weiss Amir Chief Accounting Officer Sold at will $355.30K 21 Aug 2026 · at $37.62 · 41.9% of stake Savage Brian Interim Chief Legal Officer Sold at will $285.22K 18 Sep 2026 · at $38.85 · 46.3% of stake MIGNONE ROBERTO Director Sold at will $14.36M 18 Sep 2026 · at $39.06 · 100% of stake
0 buys22 sales at will24 planned sales

Key numbers

Fiscal year 2025, ended 31 Dec 2025, as filed
Revenue
$17.26B
Net income
$1.41B
Free cash flow
$1.15B
Gross margin
51.8%
Operating margin
12.5%
Net margin
8.2%
Return on equity
17.8%
Return on capital
5.6%
Debt to equity
3.87
Revenue growth, 1 yr
4.3%
Revenue growth, 5 yr
0.7% a year

Revenue and net income

Fiscal years, as filed with the SEC · point at a year for the detail
16.7B -4B FY20 Fiscal year 2020 Revenue $16.66B Net income $3.99B Margin -24.0% 15.9B 417M FY21 Fiscal year 2021 Revenue $15.88B Net income $417.00M Margin 2.6% · growth -4.7% 14.9B -2.4B FY22 Fiscal year 2022 Revenue $14.93B Net income $2.45B Margin -16.4% · growth -6.0% 15.8B -559M FY23 Fiscal year 2023 Revenue $15.85B Net income $559.00M Margin -3.5% · growth +6.2% 16.5B -1.6B FY24 Fiscal year 2024 Revenue $16.54B Net income $1.64B Margin -9.9% · growth +4.4% 17.3B 1.4B FY25 Fiscal year 2025 Revenue $17.26B Net income $1.41B Margin 8.2% · growth +4.3%
RevenueNet incomeLoss

Latest insider transactions

From Form 4, most recent first
All of them →
DateInsiderTypeValueOf own stake
18 Sep 2026 MIGNONE ROBERTO
Director
Sold at will $14.36M 100%
18 Sep 2026 Savage Brian
Interim Chief Legal Officer
Sold at will $285.22K 46.3%
21 Aug 2026 Weiss Amir
Chief Accounting Officer
Sold at will $355.30K 41.9%
21 Aug 2026 Satchi-Fainaro Ronit
Director
Sold at will $15.46K 0.4%
17 Aug 2026 Lippman Evan
EVP, Business Development
Sold on a plan $680.29K 42.1%
5 Aug 2026 Zaks Tal Zvi
Director
Sold at will $592.71 0.0%